|Committee Member||Employment||Consultant||Speakers Bureau||Ownership/Partnership/Principal||Personal Research||Institutional, Organizational, or Other Financial Benefit||Expert Witness||Voting Recusals By Section∗|
|Clyde W. Yancy, Chair||Northwestern University Feinberg School of Medicine, Division of Cardiology—Professor of Medicine and Chief; Diversity and Inclusion—Vice Dean||None||None||None||None||None||None||None|
|Mariell Jessup, Vice Chair||University of Pennsylvania—Professor of Medicine||None||None||None||None||None||None||None|
|Biykem Bozkurt||Michael E. DeBakey VA Medical Center—The Mary and Gordon Cain Chair and Professor of Medicine||None||None||None||None||None||126.96.36.199 and 188.8.131.52.|
|Javed Butler||Stony Brook University—Division Chief of Cardiology||None||None||None||184.108.40.206 and 220.127.116.11.|
|Donald E. Casey, Jr||Thomas Jefferson College of Population Health—Adjunct Faculty; Alvarez & Marsal IPO4Health—Principal and Founder||None||None||None||None||None||None||None|
|Monica M. Colvin||University of Michigan—Associate Professor of Medicine, Cardiology||None||None||None||None||None||None||None|
|Mark H. Drazner||University of Texas Southwestern Medical Center—Professor, Internal Medicine||None||None||None||None||None|
|Gerasimos S. Filippatos||National and Kapodistrian University of Athens; Attikon University Hospital, Department of Cardiology, Heart Failure Unit—Professor of Cardiology||None||None||None||None||None||18.104.22.168 and 22.214.171.124.|
|Gregg C. Fonarow||Ahmanson-UCLA Cardiomyopathy Center—Director; UCLA Division of Cardiology—Co-Chief||None||None||None||None||126.96.36.199 and 188.8.131.52.|
|Michael M. Givertz||Brigham and Women’s Hospital—Professor of Medicine||None||None||None||None||None||184.108.40.206 and 220.127.116.11.|
|Steven M. Hollenberg||Cooper University Hospital—Director, Coronary Care Unit, Professor of Medicine||None||None||None||None||None||None||None|
|JoAnn Lindenfeld||Vanderbilt Heart and Vascular Institute—Director, Advanced Heart Failure and Transplant Section—Professor of Medicine||None||None||None||None||18.104.22.168 and 22.214.171.124.|
|Frederick A. Masoudi||University of Colorado, Denver—Associate Professor of Medicine, Division of Cardiology||None||None||None||None||None||None||None|
|Patrick E. McBride||University of Wisconsin School of Medicine and Public Health—Professor of Medicine and Family Medicine; Associate Director, Preventive Cardiology||None||None||None||None||None||None||None|
|Pamela N. Peterson||University of Colorado, Denver Health Medical Center—Associate Professor of Medicine, Division of Cardiology||None||None||None||None||None||None||None|
|Lynne W. Stevenson||Brigham and Women’s Hospital Cardiovascular Division—Director, Cardiomyopathy and Heart Failure Program||None||None||None||None||None||126.96.36.199 and 188.8.131.52.|
|Cheryl Westlake||Azusa Pacific University—Professor and Associate Dean, International and Community Programs||None||None||None||None||None||None||None|
This table represents the relationships of committee members with industry and other entities that were determined to be relevant to this document. These relationships were reviewed and updated in conjunction with all meetings and/or conference calls of the writing committee during the document development process. The table does not necessarily reflect relationships with industry at the time of publication. A person is deemed to have a significant interest in a business if the interest represents ownership of ≥5% of the voting stock or share of the business entity, or ownership of ≥$5,000 of the fair market value of the business entity, or if funds received by the person from the business entity exceed 5% of the person’s gross income for the previous year. Relationships that exist with no financial benefit are also included for the purpose of transparency. Relationships in this table are modest unless otherwise noted.
According to the ACC/AHA, a person has a relevant relationship IF: a) The relationship or interest relates to the same or similar subject matter, intellectual property or asset, topic, or issue addressed in the document; or b) the company/entity (with whom the relationship exists) makes a drug, drug class, or device addressed in the document, or makes a competing drug or device addressed in the document; or c) the person or a member of the person’s household has a reasonable potential for financial, professional, or other personal gain or loss as a result of the issues/content addressed in the document.
ACC indicates American College of Cardiology; AHA, American Heart Association; DCRI, Duke Clinical Research Institute; DSMB, data safety monitoring board; HFSA, Heart Failure Society of America; INTERMACS, The Interagency Registry for Mechanically Assisted Circulatory Support; NHLBI, National Heart, Lung, and Blood Institute; PARENT, Pulmonary artery pressure reduction with Entresto; UCLA, University of California, Los Angeles; and VA, Veterans Affairs.